|Slideshows|August 12, 2019

6 phases of return-to-play following a concussion

Author(s)Pat F. Bass III, MD, MS, MPH, Amy E Valasek, MD, MS

When a student athlete wants to return to playing following a concussion, there are 6 phases that that athlete will need to follow to get pack to the field.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

ByKeisha L. Gibson, MD, MPH

July 14th 2026

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

ByTrisha Torga, MD

July 14th 2026

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk

ByMorgan Ebert, Executive Editor

July 14th 2026

FDA accepts sNDA for vosoritide in children with achondroplasia

ByMorgan Ebert, Executive Editor

July 13th 2026

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

ByMorgan Ebert, Executive Editor

July 13th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

6 phases of return-to-play following a concussion

Related Content

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk

FDA accepts sNDA for vosoritide in children with achondroplasia

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk